Lucid Diagnostics【LUCD】銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.8103

買値

0.8103

売値

0.89

出来高

87,193

0.83 日の範囲 0.8477

0.6301 52 週間の範囲 1.51

時価総額

48.085M

前日終値

0.8428

始値

0.84

時刻

0.8104

最終取引時間

財務取引量

US$ 73,150

VWAP

0.838943

平均取引量 (3 か月)

480,401

発行済株式数

59,342,479

配当利回り

PER

-0.96

1 株当たり利益 (EPS)

-0.89

歳入

2.43M

純利益

-52.67M

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically hig... Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard. 詳細を表示

セクター

Surgical,med Instr,apparatus

業界

Surgical,med Instr,apparatus

本社

Wilmington, Delaware, USA

設立

Lucid Diagnostics Inc is listed in the Surgical,med Instr,apparatus sector of the ナスダック市場 with ticker LUCD. The last closing price for Lucid Diagnostics was US$0.84. Over the last year, Lucid Diagnostics shares have traded in a share price range of US$ 0.6301 to US$ 1.51.

Lucid Diagnostics currently has 59,342,479 shares in issue. The market capitalisation of Lucid Diagnostics is US$50.01 million. Lucid Diagnostics has a price to earnings ratio (PE ratio) of -0.96.

Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume

Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume PR Newswire NEW YORK, Jan. 13, 2025 Quarterly test volume of over 4,000 tests represented sequential increase of 45 percent NEW...

Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule PR Newswire NEW YORK, Dec. 23, 2024 NEW YORK, Dec. 23, 2024 /PRNewswire/ -- Lucid...

Form 8-K - Current report

Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters

Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters PR Newswire NEW YORK, Dec. 19, 2024 Partnership launched with fully-contracted...

Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication

Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication PR Newswire NEW YORK, Dec. 11, 2024 Study demonstrates outstanding...

Form D - Notice of Exempt Offering of Securities

Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones

Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones PR Newswire NEW YORK, Dec. 3, 2024 New convertible debt...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.0024	-0.295311923219	0.8127	0.88	0.8	126502	0.83791619	CS
4	0.0303	3.88461538462	0.78	0.9094	0.7501	261439	0.82154837	CS
12	-0.1597	-16.4639175258	0.97	1.12	0.7501	480401	0.90737905	CS
26	-0.0397	-4.67058823529	0.85	1.12	0.7201	326058	0.881744	CS
52	-0.6597	-44.8775510204	1.47	1.51	0.6301	250029	0.90594776	CS
156	-2.9997	-78.7322834646	3.81	4.0598	0.6301	140681	1.41112082	CS
260	-11.9397	-93.6447058824	12.75	13.5	0.6301	155901	2.52160481	CS

LUCD - Frequently Asked Questions (FAQ)

What is the current Lucid Diagnostics share price?

The current share price of Lucid Diagnostics is US$ 0.8103

How many Lucid Diagnostics shares are in issue?

Lucid Diagnostics has 59,342,479 shares in issue

What is the market cap of Lucid Diagnostics?

The market capitalisation of Lucid Diagnostics is USD 50.01M

What is the 1 year trading range for Lucid Diagnostics share price?

Lucid Diagnostics has traded in the range of US$ 0.6301 to US$ 1.51 during the past year

What is the PE ratio of Lucid Diagnostics?

The price to earnings ratio of Lucid Diagnostics is -0.96

What is the cash to sales ratio of Lucid Diagnostics?

The cash to sales ratio of Lucid Diagnostics is 20.78

What is the reporting currency for Lucid Diagnostics?

Lucid Diagnostics reports financial results in USD

What is the latest annual turnover for Lucid Diagnostics?

The latest annual turnover of Lucid Diagnostics is USD 2.43M

What is the latest annual profit for Lucid Diagnostics?

The latest annual profit of Lucid Diagnostics is USD -52.67M

What is the registered address of Lucid Diagnostics?

The registered address for Lucid Diagnostics is CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801

Which industry sector does Lucid Diagnostics operate in?

Lucid Diagnostics operates in the SURGICAL,MED INSTR,APPARATUS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
ASSTAsset Entities Inc	US$ 0.8998 (93.71%)	263.47M
DWTXDogwood Therapeutics Inc	US$ 3.18 (70.05%)	24.31M
USEGUS Energy Corp	US$ 3.74 (61.21%)	107.79M
DOGZDogness International Corporation	US$ 27.62 (52.60%)	1.95M
MYNAMynaric AG	US$ 0.6697 (50.83%)	3.72M
GOEVCanoo Inc	US$ 0.3748 (-72.24%)	41.38M
SHOTWSafety Shot Inc	US$ 0.1094 (-47.40%)	18.06k
ORKTOrangeKloud Technology Inc	US$ 0.7068 (-36.89%)	7.48M
HEPAHepion Pharmaceuticals Inc	US$ 0.3219 (-31.36%)	1.66M
WNWMeiwu Technology Company Ltd	US$ 0.2681 (-27.05%)	11.02M
GCTKGlucoTrack Inc	US$ 0.1226 (44.41%)	613.28M
CRKNCrown Electrokinetics Corporation	US$ 0.1121 (-10.32%)	392.52M
ASSTAsset Entities Inc	US$ 0.8998 (93.71%)	262.98M
RIMEAlgorhythm Holdings Inc	US$ 0.034599 (-16.83%)	230.08M
RGTIRigetti Computing Inc	US$ 13.97 (42.12%)	226.81M